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Mouthrinses  are  widely  used  as  adjuncts  to 
oral hygiene and in the delivery of active agents to 
the teeth and gums. The ability of these rinses to 
influence plaque formation and to alter the course 
of  gingival  inflammation  has  been  extensively 
studied and was reviewed by Kornman.1  
Natural  products  have  been  used  for  folk 
medicine  purposes  throughout  the  world 
for  thousands  of  years.  Many  of  them  have 
demonstrable  pharmacological  properties,  such 
as antimicrobial, anti-inflammatory and cytostatic, 
among others2 and more recently propolis has been 
recognized  as  useful  for  human  and  veterinary 
medicine. 
Propolis, a substance made by the honeybee, 
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AbSTRACT
Objectives: The aim of this study was to compare the effects of four different mouthrinse containing 
propolis solutions and mouthrinse containing 0.2% chlorhexidine (CHX) on oral microorganisms and 
human gingival fibroblasts.
Methods: Four different solutions of propolis were prepared and propylene glycol and alcohol 
were used as solvents for each propolis sample. Mouthrinse containing propolis was prepared at 
four different concentrations as 10%, 5%, 2.5% and 1%. Besides, CHX was used as control group. 
The antibacterial effects of five solutions on oral microorganisms were tested and their cytotoxic 
effects on human gingival fibroblasts were evaluated by agar diffusion test. 
Results: At this concentrations effectiveness of mouthrinse containing propolis samples on oral 
microorganisms were not found as effective as CHX. On the contrary, samples found less cytotoxic 
on human gingival fibroblasts than CHX. 
Conclusions: Standardized preparations of propolis can be used as a mouthrinse at appropriate 
concentrations. To obtain a standardized chemical composition, advanced researches are needed. 
(Eur J Dent 2007;1:195-201)
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is  a  potent  antimicrobial  and  anti-inflammatory 
agent.  Honeybees  collect  the  resin  from  cracks 
in the bark of trees and leaf buds. This resin is 
masticated, salivary enzymes are added and the 
partially digested material is mixed with bee wax 
and used by bees to seal holes in their honeycombs, 
smooth  out  the  internal  walls  and  protect  the 
entrance against intruders.3 In general, propolis 
is composed of 50% resin and vegetable balsam, 
30%  wax,  10%  essential  and  aromatic  oils,  5% 
pollen and 5% various other substances, including 
organic debris depending on the place and time 
of collection.4,5 The constituents of propolis vary 
widely due to climate, season, location and year, 
and its chemical formula is not stable.6-8
The most important pharmacologically active 
constituents in propolis are flavonoids (flavones, 
flavonols, falavonones) phenolics, and aromatics.9 
Flavonoids  are  well-known  plant  compounds 
that  have  antioxidant,  antibacterial,  antifungal, 
antiviral,  and  anti-inflammatory  properties.  As 
an  anti-inflammatory  agent,  propolis  is  shown 
to  inhibit  synthesis  of  prostaglandins,  activate 
the  thymus  gland,  aid  the  immune  system 
by  promoting  phagocytic  activity,  stimulate 
cellular  immunity,  and  augment  healing  effects 
on  epithelial  tissues.10-12  Additionally,  propolis 
contains elements, such as iron and zinc that are 
important for the synthesis of collagen.9,13
The  medicinal  use  of  propolis  was  nearly 
forgotten in modern era due to the discovery and 
effective  use  of  antibiotics.  Nowadays,  however, 
since several pathogens are developing resistance 
to potent antibiotics, and the latter causing side 
effects in humans, there is an increased need to 
search and screen for new antimicrobial agents is 
growing. 
Chlorhexidine (CHX), a biguanide antimicrobial 
has  a  significant  history  of  safe  and  efficacious 
use  for  oral  health  applications.14  The  in  vitro 
antimicrobial spectrum of CHX is well-documented 
in the literature. CHX is effective against a wide 
variety  of  bacteria,  including  gram-positives, 
gram-negatives,  aerobes,  and  anaerobes.15  It  is 
effective against bacteria commonly found in the 
oral  cavity16  and  against  organisms  associated 
with  diseases  of  the  oral  cavity.17  The  effects 
of  CHX  are  based  on  its  unique  properties  that 
include broad spectrum antimicrobial activity at 
low concentrations that persists over time. Clinical 
studies  demonstrate  significant  improvements 
following  CHX  treatments  on  several  indices  of 
oral health.14,18 Clinical studies indicate the effects 
of CHX on bacteria found in the saliva, tongue and 
subgingival regions.18-20 
The  aim  of  this  study  was  to  compare  the 
disinfectant  effects  of  mouthrinse  containing 
propolis and mouthrinse containing CHX on oral 
microorganisms  with  dose-response  and  time-
response  and  their  cytotoxic  effects  on  human 
gingival fibroblasts.
MATERIALS AND METHODS
Preparation of propolis containing
mouthrinse
Propolis sample was produced by honeybees 
(Apis mellifera L.) in the region of Yomra, Trabzon, 
Turkey rich in Picea orientalis, Fagus orientalis, 
Castanes  sativa,  Rhodddendron  ponticum, 
Rhododendron  luteum,  Rubus  caucasicus.21 
Propolis  was  provided  by  Trabzon  Agricultural 
Development Cooperative. Hand collected propolis 
were kept desiccated and in the dark up to their 
processing. 
Mouthrinse containing propolis was prepared at 
four different concentrations: (1) 10% w/v propolis, 
25% v/v of 70% ethanol, 10% v/v propylene glycol 
and deionized water; (2) 5% w/v propolis, 25% v/
v of  70% ethanol, 10% v/v propylene glycol and 
deionized  water;  (3)  2.5%  w/v  propolis,  25%  v/v 
of  70%  ethanol,  10%  v/v  propylene  glycol  and 
deionized water; (4) 1% w/v of  70% ethanol, 10% v/v 
propylene glycol and deionized water. Mouthrinse 
containing 0.2% chlorhexidine (CHX) was used as 
a control group. 
Bacterial strains 
A  number  of  50  subjects  treated  at  the 
Cumhuriyet  University  School  of  Dentistry  were 
scraped  the  entire  length  of  the  dorsum  of 
tongue, buccal surface, tooth surface, and dental 
plaques with a sterile brush by an oral surgeon. 
Bacteria strains, isolated from clinical specimens 
of patients, were used: Staphylococcus spp (n=15), 
Streptococcus spp (n=15), Escherichia coli (n=10) and   
six standard strains (Candida albicans ATCC 27853, 
C. albicans ATCC 76615, E. coli ATCC 25922, E. coli 
ATCC 11230, Staphylococcus aureus ATCC 29213, S. 
aureus ATCC 658). October 2007 - Vol.1
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Determination of disinfectant efficacy
For investigation all isolates were incubated in 
blood agar at 370C for 18 h, and before using all 
strains were suspended with brain hearth broth 
to 0.5 McFarland turbidity standards and diluted 
to yield a final inoculums 104  CFU (colony forming 
unit) in 2 µl as described in National Committee 
for Clinical Laboratory Standards (NCCLS, 1997). 
100  µl  from  each  bacterial  suspension  were 
transferred to micro plates. 
Serial  concentrations  of  propolis  (20%,  10%, 
5%, 2.5%) and CHX were used directly. 100 µl from 
all solution were transferred to wells. At 1st, 3rd, 
5th, 10th and 20th minutes samples were transferred 
to brain heart agar and blood agar by using an 
iron inoculum’s replicator which can transfer 2µl 
liquid. And all samples were incubated at 37ºC for 
over night. 
Gingival fibroblast cell culture
Cultures of ﬁbroblasts were established from 
gingival biopsies obtained from healthy individual. 
The biopsies were stored at 4 h at 4ºC at in hank’s 
salt  solution  containing  penicillin/streptomycin 
and amphotericin (all from Biochrom KG, Berlin, 
Germany) prior to amplification. The gingival tissue 
samples were cut into 1–2 mm3 pieces, and then 
washed twice with hank’s salt solution. Thereafter, 
the cut biopsies were placed into tissue culture 
ﬂasks (25 cm2). The explants were incubated with 
culture medium consisting of Dulbecco’s Modiﬁed 
Eagles  Medium  (DMEM,  Sigma,  St.  Louis,  MO, 
USA), 10 mm HEPES, glucose (4.5 g/L), NaHCO3 
(3.7 g/L), penicillin (100 U/mL), streptomycin (100 
mg/mL), and amphotericin (2.5 mg/mL) (all from 
Biochrom  KG,  Berlin,  Germany),  supplemented 
with 10% heat inactivated fetal calf serum (FCS) 
(PAN Systems, Aidenbach, Germany). Cells were 
grown  at  37ºC  in  a  humidiﬁed  atmosphere  of 
10%  CO2  in  air.  Culture  medium  was  renewed 
twice  per  week  until  cells  reached  confluency. 
For subcultivation, cells were detached from the 
culture flasks with 0.25% Trypsin/EDTA Solution 
(Sigma) for 3–5 min. Cells used for the experiments 
proliferated in logarithmic phase between the 7th 
and 12th passages. Cell morphology was visualized 
with phase contrast microscopy (Nikon, Eclipse, 
TS 100).
Agar diffusion method
The  agar  diffusion  tests  were  performed 
according to International Standards (International 
Standard ISO 10993–5, 1999). Briefly, the cultures 
were  harvested  using  0.25%  trypsin  solution 
(Gibco, Germany). Stock cultures were seeded in 
35 mm diameter of cell culture petri dishes (Nunc, 
Wiesbaden, Germany) at a density of 1 x l06 cells 
per petri dish and sub-cultured once a week. After 
the formation of confluent cell layer, the medium 
was removed and replaced with complete medium 
containing  1.5%  agarose  (FMC  BioProducts, 
Rockland, ME, USA). After solidifying the agarose, 
the  cells  were  stained  with  a  vital  dye  (Neutral 
Red; Sigma). During the experimental procedures, 
the cells were protected from light to prevent cell 
damage elicited by photo-activation of the stain. 
Experimental  solutions  were  applied  by  using 
sterile round Whatman papers with a diameter of 
6 mm. For the each solution, four replicate dishes 
and  four  additional  dishes  containing  positive 
and  negative  control  materials  were  prepared. 
As  negative  control,  DMEM  was  used,  while 
absolute  phenol  was  used  as  positive  control. 
After an exposition period of 24 h at 37°C, the cell 
responses were evaluated by inverted microscope 
observation. In this study, cell lysis was scored as 
follows: 0=no cell lysis detectable; 1=less than 20% 
cell lysis; 2=20% to 40% cell lysis; 3=>40% to <60% 
cell lysis; 4=60% to 80% cell lysis; 5=more than 
80% cell lysis. For each sample, one score was 
given and the median score value for all parallels 
from each samples was calculated for the lysis 
zone. Cytotoxicity was then classified as follows: 
0-0.5=non  cytotoxic;  0.6-1.9=mildly  cytotoxic; 
2.0-3.9=moderately  cytotoxic;  4.0-5.0=markedly 
cytotoxic. The median (instead of the mean) was 
calculated to describe the central tendency of the 
scores, because the results were expressed as an 
index in a ranking scale. 
RESuLTS
Effect  of  mouthrinse  containing  propolis  on 
oral microorganisms
Evaluations revealed significant effects of CHX 
on all tested microorganisms at 1st, 3rd, 5th, 10th and 
20th minutes. All microorganisms were susceptible 
to  CHX  at  1st.  In  comparison  to  the  mouthrinse 
containing  propolis,  CHX  showed  significantly 
strong  antimicrobial  activity.  In  this  study,  we European Journal of Dentistry
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evaluated  that  Streptococcus  spp  and  Candida 
albicans are susceptible to low concentrations of 
propolis. Staphylococcus spp and E. coli are more 
resistant.  All  results  were  showed  on  Table  1. 
As a result we found that 10% propolis solution 
was effective on Candida albicans ATCC 27853, C. 
albicans ATCC 76615, E. coli ATCC 25922, E. coli 
ATCC 11230, Staphylococcus aureus ATCC 29213, S. 
aureus at 1st minute. 
Cytotoxicity of mouthrinse containing propolis 
on gingival cells
Cytotoxic  effect  of  mouthrinse  containing 
propolis and CHX were investigated using the agar 
diffusion test for 24 h. At no point in time, cytotoxic 
reactions were detected in any of the four replicates 
of  with  mouthrinse  5%,  2.5%  and  1.25%.  (non 
cytotoxic).  There  was  no  zone  of  decolonization 
around the samples. Even the cells directly under 
this concentration of mouthrinse, which could be 
examined by removing the materials from the agar 
overlay, did not show any signs of cell injury and 
were similar to negative controls. Concentration of 
mouthrinse containing propolis at %10 was ranked 
mildly  cytotoxic.  CHX  was  showed  moderately 
cytotoxic. On the overall, lysis index score was 5 
(markedly cytotoxic) in positive control group and 
0 (non cytotoxic) in negative control group.
 Effect of mouthrinse containing propolis
Table 1. Resistance of oral microorganism to propolis.
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1st minute
10 - - 2+ + - - - - -
5 1+ - 2+ + + + - - -
2.5 2+ - 2+ + + + + - -
1.25 5+ - 3+ + + + + - -
3rd minute
10 - - 2+ + - - - - -
5 1+ - 2+ + + + - - -
2.5 2+ - 2+ + + + + - -
1.25 5+ - 3+ + + + + - -
5th minute
10 - - 2+ + - - - - -
5 1+ - 2+ + + + - - -
2.5 2+ - 2+ + + + + - -
1.25 5+ - 3+ + + + + - -
10th minute
10 - - - + - - - - -
5 1+ - 2+ + + + - - -
2.5 2+ - 2+ + + + + - -
1.25 5+ - 3+ + + + + - -
20th minute
10 - - - - - - - - -
5 - - - - - - - - -
2.5 2+ - 2+ + + + + - -
1.25 5+ - 3+ + + + + - -
- : susceptible  +: resistant
* Since CHX showed strong antimicrobial activity against all microorganisms even at 1st minute, it was not added to table.October 2007 - Vol.1
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DISCuSSION
Propolis  has  been  extensively  studied  for 
its  biological  properties,  mainly  antimicrobial 
activity.22-28 Some authors found propolis samples 
active  only  against  gram-positive  bacteria  and 
some  fungi.4,9  Additionally,  others  found  also 
weak  activity  against  gram-negative  bacteria.5,29 
Our  experimental  solution  had  significant  effect 
on gram-positive strains than on gram-negative 
strain. Also, we can say that experimental solutions 
showed enough effect on gram-negative strains 
and on Candida strains.
Mechanisms  of  activity  of  propolis  against 
microorganisms  are  still  controversial.  Some 
components  present  in  propolis  extracts  like 
flavonoids (quercetin, galangin, pinocembrin) and 
caffeic acid, benzoic acid, cinnamic acid, probably 
act on the microbial membrane or cell wall site, 
causing  functional  and  structural  damages.9,30,31 
According to Amoros et al32 and Bonhevi et al33 its 
activity against microorganisms is more related 
to the synergistic effect of flavonoids (and other 
phenolics)  than  to  the  individual  compounds. 
These  findings  are  in  agreement  with  those  of 
Takaisikikuni and Schilcher34 who observed that 
the antibacterial action against Strep. agalactiae was 
complex, involving several mechanisms such as 
the formation of pseudomulticellular streptococci; 
disorganization of the cytoplasm, the cytoplasmatic 
membrane, and the cell wall; partial bacteriolysis; 
and inhibition of protein synthesis. They concluded 
that a simple analogy could not be made with the 
mode  of  action  of  any  classic  antibiotics.  There 
are no reports dealing with bacterial resistance 
to constituents of propolis and these properties 
of propolis may influence the success of antibiotic 
therapy in the oral cavity.35 
Propolis  has  mucoprotective  properties, 
as  has  been  described  for  oral  and  gastric 
mucosa.36 The mucosal interfaces of the human 
body are colonized by microbial flora indigenous 
to  these  locations.  A  well-known  example  is 
the  human  mouth  that  harbors  a  diverse  and 
significant  numbers  of  microorganisms.37  Oral 
microorganisms are found in the saliva as non-
adhering populations and as plaque, a microbial 
biofilm, adherent to the surfaces of the tooth and 
tongue.  Clinical  researches  have  examined  the 
association  between  these  microorganisms  and 
specific  oral  conditions  such  as  dental  caries, 
periodontal disease and oral malodor. Koo et al25 
stated that mouthrinse containing propolis showed 
significant reduction of dental plaque compared 
to  the  placebo  and  also  significant  inhibition  of 
insoluble polysaccharide formation. Muray et al38 
found that a mouthrinse containing 10% propolis 
had no significant effect on dental plaque regrowth 
although a slight reduction (14%) was observed. 
On the other hand, studies showed that propolis 
prevented caries development.39,40 
Propolis  is  relatively  non-toxic  and  studies 
have exhibited a no-effect level in a mice study 
of 1400 mg/kg weight/day leading the authors to 
propose that a safe dose in humans would be 1.4 
mg/kg weight/day, or approximately 70 mg/day.41 
Our  experimental  propolis  solutions  showed 
significant activity on Candida strains; so it can be 
useful for preventing candidial infections.
The development of new therapies for treatment 
of  oral  cavity  diseases  is  of  great  importance 
since  the  systemic  and  local  administration  of 
antimicrobials  brings  about  several  problems. 
Some  of  these  problems  are:  selection  of 
multiresistant  microorganisms,  interbacterial 
transfer  of  resistance  determinants  and 
unpleasant side effects. A relatively large number 
of  chemical  agents,  which  are  mostly  synthetic 
compounds, have been used for many purposes, 
control  of  dental  plaque,  elimination  of  oral 
pathogens, against malodor, etc. The experimental 
mouthrinse solutions showed significant inhibitory 
activity  against  on  oral  microorganisms  not  as 
effective as CHX; but was found less cytotoxic on 
human gingival fibroblasts. 
One  problem  associated  with  the  medical 
preparation and use of propolis is its heterogeneous 
chemical  composition.  The  concentration  of  the 
various  constituents  largely  depends  on  factors 
like geographic origin, plant sources, and proper 
collection and handling techniques. New studies, 
using advanced researches are needed to solve this 
problem. If a standard chemical composition can 
be obtained, standard effects can be obtained.
CONCLuSIONS 
Based  on  our  results,  we  suggest  that 
the  administration  of  propolis  at  appropriate 
concentrations  might  be  effective  on  oral 
microorganisms  and  non-cytotoxic  to  gingival 
fibroblasts.  In  addition,  according  to  previous European Journal of Dentistry
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studies,  propolis  prevents  dental  caries  and 
periodontal  disease,  since  it  demonstrated 
significant  antimicrobial  activity  against  the 
microorganisms involved in such diseases. These 
results  give  hope  to  us  that  propolis,  a  natural 
product,  can  be  used  for  oral  rehabilitation  of 
patients for various purposes. 
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